Site search | Alfred Health

World-first trial in silicosis

Patients around the globe who suffer from silicosis - a potentially fatal lung disease - are a step closer to a viable treatment for the disease, thanks to a three-year research funding commitment from Zaparas Lawyers.

/news/world-first-trial-in-silicosis

Alfred Health GP News - June 2025 pdf

Alfred_Health_GP_News_-_June_2025.pdf

The Alfred - Elbow (Radial Head) Fracture PDF

https://app.prompt.org.au/download/249797?code=c4128c07-bb42-4618-ab1f-fcff87273b85

Allied Health Student Orientation Manual 2025 pdf

Allied-Health-Student-Orientation-Manual-2025.pdf

Alfred Health - Fatigue after brain injury PDF

https://app.prompt.org.au/download/249672?code=4e593ec9-eacc-4491-9efa-e77cf55903b5

National Lung Cancer Screening Program – General practitioner resource guide

https://www.health.gov.au/our-work/nlcsp/for-healthcare-providers

National Lung Cancer Screening Program information for healthcare providers

https://www.health.gov.au/our-work/nlcsp/for-healthcare-providers

NLCSP screening request (Low Dose Chest CT) pdf

ALF_-_NLCSP_screening_request_(Low_Dose_Chest_CT)_F-RAD-414.pdf

A Phase 1, Open-Label, Multicenter Study of INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms (NCT05936359)

/

Comparing speech pathology and amitriptyline to speech pathology and placebo for the management of vocal cord dysfunction: a randomised controlled trial (ACTRN12619000158167)

/